Guggenheim Capital LLC Spring Works Therapeutics, Inc. Transaction History
Guggenheim Capital LLC
- $10.6 Billion
- Q1 2025
A detailed history of Guggenheim Capital LLC transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Guggenheim Capital LLC holds 18,029 shares of SWTX stock, worth $834,201. This represents 0.01% of its overall portfolio holdings.
Number of Shares
18,029
Previous 20,129
10.43%
Holding current value
$834,201
Previous $727,000
9.35%
% of portfolio
0.01%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding SWTX
# of Institutions
361Shares Held
63.1MCall Options Held
5.81MPut Options Held
2.55M-
Vanguard Group Inc Valley Forge, PA7.08MShares$328 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$260 Million0.0% of portfolio
-
State Street Corp Boston, MA2.92MShares$135 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.58MShares$120 Million0.01% of portfolio
-
Woodline Partners LP San Francisco, CA2.14MShares$99.2 Million0.66% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.89B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...